Adalimumab added to a treat-to-target strategy with...

Annals of the Rheumatic Diseases 2014 / 04 Vol. 73; Iss. 4

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial

Horslev-Petersen, K., Hetland, M. L., Junker, P., Podenphant, J., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Horn, H. C., Ammitzboll, C. G., Jor
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
73
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-202735
Date:
April, 2014
File:
PDF, 775 KB
english, 2014
Conversion to is in progress
Conversion to is failed